Pre-pregnancy maternal plasma cytokine levels and risks of small-for-gestational-age at birth

References

• Katz J, Lee AC, Kozuki N, et al. Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: a pooled country analysis. Lancet 2013;382:417–25
   PubMed Web of Science ®Google Scholar
• Georgiou HM, Thio YS, Russell C, et al. Association between maternal serum cytokine profiles at 7-10 weeks’ gestation and birthweight in small for gestational age infants. Am J Obstet Gynecol 2011;204:415e1–e12
   Web of Science ®Google Scholar
• Smith GC, Stenhouse EJ, Crossley JA, et al. Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 2002;87:1762–7
   PubMed Web of Science ®Google Scholar
• Robertson SA, Chin PY, Glynn DJ, Thompson JG. Peri-conceptual cytokines – setting the trajectory for embryo implantation, pregnancy and beyond. Am J Reprod Immunol 2011;66:2–10
   PubMed Web of Science ®Google Scholar
• Nguyen PH, Lowe AE, Martorell R, et al. Rationale, design, methodology and sample characteristics for the Vietnam pre-conceptual micronutrient supplementation trial (PRECONCEPT): a randomized controlled study. BMC Public Health 2012;12:898
   PubMed Web of Science ®Google Scholar
• Williams RL, Creasy RK, Cunningham GC, et al. Fetal growth and perinatal viability in California. Obstet Gynecol 1982;59:624–32
   PubMed Web of Science ®Google Scholar
• Cogill B. Anthropometric indicators measurement guide. Washington (DC): Food and Nutrition Technical Assistance (FANTA) Project, FHI 360; 2003
   Google Scholar
• Fu Q, Zhu J, Van Eyk JE. Comparison of multiplex immunoassay platforms. Clin Chem 2010;56:314–18
   PubMed Web of Science ®Google Scholar
• Erhardt JG, Estes JE, Pfeiffer CM, et al. Combined measurement of ferritin, soluble transferrin receptor, retinol binding protein, and C-reactive protein by an inexpensive, sensitive, and simple sandwich enzyme-linked immunosorbent assay technique. J Nutr 2004;134:3127–32
   PubMed Web of Science ®Google Scholar
• Breeze AC, Lees CC, eds. Prediction and perinatal outcomes of fetal growth restriction. Seminars in fetal and neonatal medicine. vol. 12. Cambridge, UK: Elsevier; 2007:383--97
   Google Scholar
• Hui D, Okun N, Murphy K, et al. Combinations of maternal serum markers to predict preeclampsia, small for gestational age, and stillbirth: a systematic review. J Obstet Gynaecol Canada 2012;34:142–53
   PubMedGoogle Scholar
• Tjoa ML, Oudejans CB, van Vugt JM, et al. Markers for presymptomatic prediction of preeclampsia and intrauterine growth restriction. Hypertens Pregnancy 2004;23:171–89
   PubMed Web of Science ®Google Scholar
• Briana DD, Liosi S, Gourgiotis D, et al. Fetal concentrations of the growth factors TGF-α and TGF-β1 in relation to normal and restricted fetal growth at term. Cytokine 2012;60:157–61
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Papageorghiou AT, Kennedy SH, Villar J. Novel biomarkers for predicting intrauterine growth restriction: a systematic review and meta-analysis. BJOG 2013;120:681–94
   PubMed Web of Science ®Google Scholar
• Hahn-Zoric M, Hagberg H, Kjellmer I, et al. Aberrations in placental cytokine mRNA related to intrauterine growth retardation. Pediatr Res 2002;51:201–6
   PubMed Web of Science ®Google Scholar
• Malamitsi-Puchner A, Briana DD, Boutsikou M, et al. Perinatal circulating visfatin levels in intrauterine growth restriction. Pediatrics 2007;119:e1314–18
   PubMed Web of Science ®Google Scholar
• Neta GI, von Ehrenstein OS, Goldman LR, et al. Umbilical cord serum cytokine levels and risks of small-for-gestational-age and preterm birth. Am J Epidemiol 2010;171:859–67
   PubMed Web of Science ®Google Scholar
• Briana DD, Boutsikou M, Baka S, et al. Perinatal changes of plasma resistin concentrations in pregnancies with normal and restricted fetal growth. Neonatology 2008;93:153–7
   PubMed Web of Science ®Google Scholar
• Lindner U, Tutdibi E, Binot S, et al. Levels of cytokines in umbilical cord blood in small for gestational age preterm infants. Klin Padiatr 2013;225:70–4
   PubMed Web of Science ®Google Scholar
• Chegini N, Ma C, Roberts M, et al. Differential expression of interleukins (IL) IL-13 and IL-15 throughout the menstrual cycle in endometrium of normal fertile women and women with recurrent spontaneous abortion. J Reprod Immunol 2002;56:93–110
   PubMed Web of Science ®Google Scholar
• Dealtry GB, Clark DE, Sharkey A, et al. Expression and localization of the Th2-type cytokine interleukin-13 and its receptor in the placenta during human pregnancy. Am J Reprod Immunol 1998;40:283–90
   PubMed Web of Science ®Google Scholar
• Sykes L, MacIntyre DA, Yap XJ, et al. The Th1:Th2 dichotomy of pregnancy and preterm labour. Mediat Inflamm 2012;2012:967629
   PubMed Web of Science ®Google Scholar
• Mor G, Cardenas I, Abrahams V, Guller S. Inflammation and pregnancy: the role of the immune system at the implantation site. Ann NY Acad Sci 2011;1221:80–7
   PubMed Web of Science ®Google Scholar
• Engel SA, Olshan AF, Savitz DA, et al. Risk of small-for-gestational age is associated with common anti-inflammatory cytokine polymorphisms. Epidemiology 2005;16:478–86
   PubMed Web of Science ®Google Scholar
• Edwards DR, Romero R, Kusanovic JP, et al. Polymorphisms in maternal and fetal genes encoding for proteins involved in extracellular matrix metabolism alter the risk for small-for-gestational-age. J Matern Fetal Neonatal Med 2011;24:362–80
   PubMed Web of Science ®Google Scholar
• Casano-Sancho P, Lopez-Bermejo A, Fernandez-Real JM, et al. The tumour necrosis factor (TNF)-alpha-308GA promoter polymorphism is related to prenatal growth and postnatal insulin resistance. Clin Endocrinol 2006;64:129–35
   PubMed Web of Science ®Google Scholar
• Sziller I, Nguyen D, Halmos A, et al. An A > G polymorphism at position -670 in the Fas (TNFRSF6) gene in pregnant women with pre-eclampsia and intrauterine growth restriction. Mol Hum Reprod 2005;11:207–10
   PubMed Web of Science ®Google Scholar
• Roberts M, Luo X, Chegini N. Differential regulation of interleukins IL-13 and IL-15 by ovarian steroids, TNF-alpha and TGF-beta in human endometrial epithelial and stromal cells. Mol Hum Reprod 2005;11:751–60
   PubMed Web of Science ®Google Scholar
• Zhu Z, Ma B, Zheng T, et al. IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling. J Immunol 2002;168:2953–62
   PubMed Web of Science ®Google Scholar
• Darling AM, McDonald CR, Conroy AL, et al. Angiogenic and inflammatory biomarkers in midpregnancy and small-for-gestational-age outcomes in Tanzania. Am J Obstet Gynecol 2014;211:509 e1–8
   PubMed Web of Science ®Google Scholar
• Ip WK, Wong CK, Lam CW. Interleukin (IL)-4 and IL-13 up-regulate monocyte chemoattractant protein-1 expression in human bronchial epithelial cells: involvement of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2 and Janus kinase-2 but not c-Jun NH2-terminal kinase 1/2 signalling pathways. Clin Exp Immunol 2006;145:162–72
   PubMed Web of Science ®Google Scholar
• Kallen B, Finnstrom O, Nygren KG, Otterblad Olausson P. Association between preterm birth and intrauterine growth retardation and child asthma. Eur Resp J 2013;41:671–6
   PubMed Web of Science ®Google Scholar
• Mu M, Ye S, Bai MJ, et al. Birth weight and subsequent risk of asthma: a systematic review and meta-analysis. Heart Lung Circ 2014;23:511–9
   PubMed Web of Science ®Google Scholar
• Williams TJ, Jones CA, Miles EA, et al. Fetal and neonatal IL-13 production during pregnancy and at birth and subsequent development of atopic symptoms. J Aller Clin Immunol 2000;105:951–9
   PubMed Web of Science ®Google Scholar